Article thumbnail

Identification of transcriptional networks responding to pyrroloquinoline quinone dietary supplementation and their influence on thioredoxin expression, and the JAK/STAT and MAPK pathways

By Eskouhie Tchaparian, Lisa Marshal, Gene Cutler, Kathryn Bauerly, Winyoo Chowanadisai, Michael Satre, Calliandra Harris and Robert B. Rucker

Abstract

PQQ (pyrroloquinoline quinone) improves energy utilization and reproductive performance when added to rodent diets devoid of PQQ. In the present paper we describe changes in gene expression patterns and transcriptional networks that respond to dietary PQQ restriction or pharmacological administration. Rats were fed diets either deficient in PQQ (PQQ−) or supplemented with PQQ (approx. 6 nmol of PQQ/g of food; PQQ+). In addition, groups of rats were either repleted by administering PQQ to PQQ− rats (1.5 mg of PQQ intraperitoneal/kg of body weight at 12 h intervals for 36 h; PQQ−/+) or partially depleted by feeding the PQQ− diet to PQQ+ rats for 48 h (PQQ+/−). RNA extracted from liver and a Codelink® UniSet Rat I Bioarray system were used to assess gene transcript expression. Of the approx. 10000 rat sequences and control probes analysed, 238 were altered at the P<0.01 level by feeding on the PQQ− diet for 10 weeks. Short-term PQQ depletion resulted in changes in 438 transcripts (P<0.01). PQQ repletion reversed the changes in transcript expression caused by PQQ deficiency and resulted in an alteration of 847 of the total transcripts examined (P<0.01). Genes important for cellular stress (e.g. thioredoxin), mitochondriogenesis, cell signalling [JAK (Janus kinase)/STAT (signal transducer and activator of transcription) and MAPK (mitogen-activated protein kinase) pathways] and transport were most affected. qRT-PCR (quantitative real-time PCR) and functional assays aided in validating such processes as principal targets. Collectively, the results provide a mechanistic basis for previous functional observations associated with PQQ deficiency or PQQ administered in pharmacological amounts

Topics: Research Article
Publisher: Portland Press Ltd.
OAI identifier: oai:pubmedcentral.nih.gov:2907713
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A comprehensive evaluation of SAM, the SAM R-package and a simple modification to improve its performance.
  2. (2004). Activation of p38 MAPK is required for Bax translocation to mitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes.
  3. (2007). Activation of Ras signaling pathways by pyrroloquinoline quinone in NIH3T3 mouse fibroblasts.
  4. (2002). An assessment of Motorola CodeLink microarray performance for gene expression profiling applications. Nucleic Acids Res.
  5. (1996). Bcl-2 targets the protein kinase Raf-1 to mitochondria.
  6. (2005). Biochemistry: is pyrroloquinoline quinone a vitamin?
  7. (2005). Biochemistry: role of PQQ as a mammalian enzyme cofactor?
  8. (1999). Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milk.
  9. (2007). Codelink: an R package for analysis of GE Healthcare gene expression bioarrays.
  10. (2006). Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury.
  11. (2008). Dietary Modulation of Cell Signaling Pathways,
  12. (1994). Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice.
  13. (1991). Does the intestinal microflora synthesize pyrroloquinoline quinone?
  14. (1993). Effects of pyrroloquinoline quinone (PQQ) and PQQ-oxazole on DNA synthesis of cultured human fibroblasts.
  15. (2005). Enhanced rat sciatic nerve regeneration through silicon tubes filled with pyrroloquinoline quinone.
  16. (1997). Escherichia coli is unable to produce pyrroloquinoline quinone (PQQ).
  17. (1993). Failure to verify high levels of pyrroloquinoline quinone in eggs and skim milk.
  18. (2009). Function of mitochondrial Stat3 in cellular respiration.
  19. (2006). High-throughput real-time quantitative reverse transcription PCR.
  20. (2007). Integration of statistical inference methods and a novel control measure to improve sensitivity and specificity of data analysis in expression profiling studies.
  21. (1991). Intestinal absorption and tissue distribution of [14C]pyrroloquinoline quinone in mice.
  22. (2008). Involvement of thio-, peroxi-, and glutaredoxins in cellular redox-dependent processes.
  23. (1995). Levels of pyrroloquinoline quinone in various foods.
  24. (1985). Method of enzymatic determination of pyrroloquinoline quinone.
  25. (2007). Mitochondrial targeting of quinones: therapeutic implications.
  26. (2005). Mitochondrial targeting signal in human neuropeptide Y gene.
  27. (2007). Mitochondrial transcription and its regulation in mammalian cells.
  28. (1999). Modulation of AP-1/ATF transcription factor activity by the adenovirus-E1A oncogene products.
  29. (2001). Neuropeptide Y suppressed the T3-induced rise in brown fat mitochondrial respiration in hypothyroid rats.
  30. (1990). New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.
  31. (2003). Nutritional biochemistry: a new redox-cofactor vitamin for mammals.
  32. (2009). Potential physiological importance of pyrroloquinoline quinone.
  33. (2010). Pro-oxidant action of pyrroloquinoline quinone: characterization of protein oxidative modifications.
  34. (2009). Protection of pyrroloquinoline quinone against methylmercury-induced neurotoxicity via reducing oxidative stress. Free Radical Res.
  35. (2009). Protective effect of pyrroloquinoline quinone against Aβ-induced neurotoxicity in human neuroblastoma SH-SY5Y cells.
  36. (2004). Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion.
  37. (2009). Pyrroloquinoline quinone attenuates iNOS gene expression in the injured spinal cord.
  38. (2005). Pyrroloquinoline quinone enhances regeneration of transected sciatic nerve in rats.
  39. (2003). Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets.
  40. (2006). Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice.
  41. (2006). Pyrroloquinoline quinone nutritional status alters lysine metabolism and modulates mitochondrial DNA content in the mouse and rat.
  42. (2008). Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1.
  43. (2010). Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1α expression.
  44. (2003). Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways.
  45. (2002). Reproducible quantitative PCR of mitochondrial and nuclear DNA copy number using the LightCycler. Methods Mol.
  46. (2001). Significance analysis of microarrays applied to the ionizing radiation response.
  47. (1997). Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.
  48. (2008). The influence of diet composition on phase I and II biotransformation enzyme induction.
  49. (2009). The role of mitochondria in health
  50. (2009). The versatile role of MSKs in transcriptional regulation.
  51. (1992). Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectrometry.
  52. (2007). Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators.